PRINTORGANS Trademark

Trademark Overview


On Tuesday, July 9, 2024, a trademark application was filed for PRINTORGANS with the United States Patent and Trademark Office. The USPTO has given the PRINTORGANS trademark a serial number of 98638835. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Saturday, February 8, 2025. This trademark is owned by PrintBio, Inc.. The PRINTORGANS trademark is filed in the Medical Instrument Products category with the following description:

Bioprinters; 3D Bioprinters; 6-Dimensional Bioprinters; Bioprinted organs; Bioprinted organs, namely ears; Bioprinted organs, namely, livers; Bioprinted organs, namely, kidneys; Bioprinted organs, namely portions of ears; Bioprinted organs, namely portions of livers; Bioprinted organs, namely portions of kidneys; Autologous bioprinted organs; Autologous bioprinted organs, namely ears; Autologous bioprinted organs, namely livers; Autologous bioprinted organs, namely kidneys; Autologous bioprinted organs, namely portions of ears; Autologous bioprinted organs, namely portions of livers; Autologous bioprinted organs, namely portions of kidneys; Bioprinted structures for organs; Autologous bioprinted structures for organs; Organ replacement therapy; On demand organ replacement therapy; On demand organ replacement therapy using bioprinting; On demand organ replacement therapy using autologous bioprinting; On demand organ replacement therapy using 3D Bioprinting; Ink for Bioprinters; Ink for ...
printorgans

General Information


Serial Number98638835
Word MarkPRINTORGANS
Filing DateTuesday, July 9, 2024
Status641 - NON-FINAL ACTION - MAILED
Status DateSaturday, February 8, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Pseudo MarkPRINT ORGANS
Goods and ServicesBioprinters; 3D Bioprinters; 6-Dimensional Bioprinters; Bioprinted organs; Bioprinted organs, namely ears; Bioprinted organs, namely, livers; Bioprinted organs, namely, kidneys; Bioprinted organs, namely portions of ears; Bioprinted organs, namely portions of livers; Bioprinted organs, namely portions of kidneys; Autologous bioprinted organs; Autologous bioprinted organs, namely ears; Autologous bioprinted organs, namely livers; Autologous bioprinted organs, namely kidneys; Autologous bioprinted organs, namely portions of ears; Autologous bioprinted organs, namely portions of livers; Autologous bioprinted organs, namely portions of kidneys; Bioprinted structures for organs; Autologous bioprinted structures for organs; Organ replacement therapy; On demand organ replacement therapy; On demand organ replacement therapy using bioprinting; On demand organ replacement therapy using autologous bioprinting; On demand organ replacement therapy using 3D Bioprinting; Ink for Bioprinters; Ink for 3DBioprinters; Cell culture apparatus for Bioprinters; Cell culture apparatus for 3D Bioprinters; Cell culture apparatus for autologous Bioprinting; Cell culture apparatus for organ replacement therapy; Cell culture apparatus for autologous organ replacement therapy

Classification Information


International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateTuesday, July 9, 2024
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NamePrintBio, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSurfside, FL 33154

Trademark Events


Event DateEvent Description
Tuesday, July 9, 2024NEW APPLICATION ENTERED
Friday, January 31, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, February 1, 2025ASSIGNED TO EXAMINER
Saturday, February 8, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Saturday, February 8, 2025NON-FINAL ACTION WRITTEN
Saturday, February 8, 2025NON-FINAL ACTION E-MAILED